Ocean Biomedical, Inc. (OCEA)
OTCMKTS · Delayed Price · Currency is USD
0.0010
-0.0001 (-9.09%)
Feb 3, 2026, 4:00 PM EST
Ocean Biomedical Market Cap
Ocean Biomedical has a market cap or net worth of $232.37 thousand as of February 4, 2026. Its market cap has decreased by -98.77% in one year.
Market Cap
232.37K
Enterprise Value
15.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 8, 2021, Ocean Biomedical's market cap has decreased from 105.68M to 232.37K, a decrease of -99.78%. That is a compound annual growth rate of -76.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 232.37K | 100.00% |
| Dec 31, 2025 | 116.18K | -99.40% |
| Dec 31, 2024 | 19.28M | -14.29% |
| Dec 29, 2023 | 22.50M | -79.59% |
| Dec 30, 2022 | 110.24M | 4.10% |
| Dec 31, 2021 | 105.89M | 0.20% |
| Nov 8, 2021 | 105.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regen BioPharma | 645.54K |
| Altamira Therapeutics | 628.70K |
| Regenerative Medical Technology Group | 613.59K |
| Bio-Path Holdings | 536.05K |
| Innovation Pharmaceuticals | 475.89K |
| Hepion Pharmaceuticals | 403.23K |
| Helix BioMedix | 393.24K |
| Actavia Life Sciences | 385.91K |